NBN-RIPK2 Fusion FISH Probe
The NBN-RIPK2 Fusion FISH Probe is used to confirm a fusion of the NBN and RIPK2 genes. The fusion of the NBN and RIPK2 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| NBN-RIPK2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| NBN-RIPK2-20-AQAQ | 20 (40 μL) | 200 μL |
|
NBN Gene Summary
Mutations in this gene are associated with Nijmegen breakage syndrome, an autosomal recessive chromosomal instability syndrome characterized by microcephaly, growth retardation, immunodeficiency, and cancer predisposition. The encoded protein is a member of the MRE11/RAD50 double-strand break repair complex which consists of 5 proteins. This gene product is thought to be involved in DNA double-strand break repair and DNA damage-induced checkpoint activation. [provided by RefSeq, Jul 2008]
Gene Name: Nibrin
Chromosome: CHR8: 90945563 -90996899
Locus: 8q21.3
RIPK2 Gene Summary
This gene encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein contains a C-terminal caspase activation and recruitment domain (CARD), and is a component of signaling complexes in both the innate and adaptive immune pathways. It is a potent activator of NF-kappaB and inducer of apoptosis in response to various stimuli. [provided by RefSeq, Jul 2008]
Gene Name: Receptor Interacting Serine/threonine Kinase 2
Chromosome: CHR8: 90769974 -90803292
Locus: 8q21.3
Gene Diseases
The NBN RIPK2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|